The effect of moderate substitution of dietary carbohydrates by fats on serum levels of adipocytokines, inflammatory indices, and biomarkers of endothelial function amongwomen with metabolic syndrome

Journal of Zanjan University of Medical Sciences and Health Services

Volumn 20, Issue 83, 2012, Pages

  Rajaie, S ^a   Azadbakht, L ^b   Saneei, P ^a   Khazaei, M ^c   Esmaillzadeh, A ^b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adipocytokines; Carbohydrate; CRP; Diet; Endothelial function; Metabolic syndrome; Obesity

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 6; LEPTIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD LEVEL; CARBOHYDRATE INTAKE; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET RESTRICTION; ENDOTHELIAL FUNCTION; FAT INTAKE; FEMALE; HUMAN; INFLAMMATION; METABOLIC SYNDROME X; OBESITY; RANDOMIZED CONTROLLED TRIAL;

EID: 84927560629     PISSN: 16069366     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Kolovou GD, Anagnostopoulou KK, Salpea KD, Mikhailidis DP. The prevalence of metabolic syndrome in various populations. Am J Med Sci. 2007; 333: 362-371.
2. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005; 28: 1769-1778.
3. Ford ES, Li C, Zhao G. Prevalence and correlates of metabolic syndrome based on a harmonious definition among adults in the US. J Diabetes. 2010; 2: 180-193.
4. Delavari A, Forouzanfar MH, Alikhani S, Sharifian A, Kelishadi R. First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: the national survey of risk factors for noncommunicable diseases of Iran. Diabetes Care. 2009; 32: 1092-1097.
5. Esmaillzadeh A, Mirmiran P, Azadbakht L, Etemadi A, Azizi F. High prevalence of the metabolic syndrome in Iranian adolescents. Obesity (Silver Spring). 2006; 14: 377-382.
6. Cameron AJ, Shaw JE, Zimmet PZ. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am. 2004; 33: 351-375.
7. Wu W, Wang M, Sun Z, Wang X, Miao J, Zheng Z. The predictive value of TNF-alpha and IL-6 and the incidence of macrovascular complications in patients with type 2 diabetes. Acta Diabetol. 2012; 49: 3-7.
8. Neurath MF, Finotto S. IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer. Cytokine Growth Factor Rev. 2011; 22: 83-89.
9. Giugliano D, Ceriello A, Esposito K. The effects of diet on inflammation: emphasis on the metabolic syndrome. J Am Coll Cardiol. 2006; 48: 677-685.
10. Schenk S, Saberi M, Olefsky JM. Insulin sensitivity: modulation by nutrients and inflammation. J Clin Invest. 2008; 118: 2992 3002.
11. Volek JS, Phinney SD, Forsythe CE, et al. Carbohydrate restriction has a more favorable impact on the metabolic syndrome than a low fat diet. Lipids. 2009; 44: 297-309.
12. Muzio F, Mondazzi L, Harris WS, Sommariva D, Branchi A. Effects of moderate variations in the macronutrient content of the diet on cardiovascular disease risk factors in obese patients with the metabolic syndrome. Am J Clin Nutr. 2007; 86: 946-951.
13. Feinman RD, Volek JS, Westman EC. Dietary carbohydrate restriction in the treatment of diabetes and metabolic syndrome. Clin Nut Insight. 2008; 12: 1-5.
14. Forsythe CE, Phinney SD, Fernandez ML, et al. Comparison of low fat and low carbohydrate diets on circulating fatty acid composition and markers of inflammation. Lipids. 2008; 43: 65-77.
15. O'Brien KD, Brehm BJ, Seeley RJ, et al. Dietinduced weight loss is associated with decreases in plasma serum amyloid A and C-reactive protein independent of dietary macronutrient composition in obese subjects. J Clin Endocrinol Metab. 2005; 90: 2244-2249.
16. Rankin JW, Turpyn AD. Low carbohydrate, high fat diet increases C-reactive protein during weight loss. J Am Coll Nutr. 2007; 26: 163-169.
17. Sharman MJ, Volek JS. Weight loss leads to reductions in inflammatory biomarkers after a very-low-carbohydrate diet and a low-fat diet in overweight men. Clin Sci (Lond).2004;107:365-369.
18. Kimiagar SM, Ghaffarpour M, Houshiar-Rad A, Hormozdyari H, Zellipour L. Food consumption pattern in the Islamic Republic of Iran and its relation to coronary heart disease. East Mediterr Health J. 1998; 4: 539-547.
19. Koren MS, Purnell JQ, Breen PA, Matthys CC, Callahan HS, Weigle DS. Plasma C-reactive protein concentration is not affected by isocaloric dietary fat reduction. Nutrition. 2006; 22: 444-448.
20. Hudgins LC, Baday A, Hellerstein MK, et al. The effect of dietary carbohydrate on genes for fatty acid synthase and inflammatory cytokines in adipose tissues from lean and obese subjects. J Nutr Biochem. 2008; 19: 237-245.
21. Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004; 109: 433-438.
22. Fleiss JL. The design and analysis of clinical experiments. London: John Wiley and Sons; 1986.
23. Ainsworth BE, Haskell WL, Whitt MC, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc. 2000; 32: S498-S504.
24. Uhlar CM, Whitehead AS. Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem. 1999; 265: 501-523.
25. Urieli-Shoval S, Linke RP, Matzner Y. Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states. Curr Opin Hematol. 2000; 7: 64-69.
26. King VL, Thompson J, Tannock LR. Serum amyloid A in atherosclerosis. Curr Opin Lipidol. 2011; 22: 302-307.
27. Banka CL, Yuan T, de Beer MC, Kindy M, Curtiss LK, de Beer FC. Serum amyloid A (SAA): influence on HDL-mediated cellular cholesterol efflux. J Lipid Res. 1995; 36: 1058-1065.
28. Zhao Y, He X, Shi X, et al. Association between serum amyloid A and obesity: a metaanalysis and systematic review. Inflamm Res. 2010; 59: 323-334.
29. Fischer K, Theil G, Hoda R, Fornara P. Serum amyloid A: a biomarker for renal cancer. Anticancer Res. 2012; 32: 1801-1804.
30. Zhang G, Sun X, Lv H, Yang X, Kang X. Serum amyloid A: A new potential serum marker correlated with the stage of breast cancer. Oncol Lett. 2012; 3: 940-944.
31. Moshkovskii SA. Why do cancer cells produce serum amyloid a acute-phase protein? Biochemistry (Mosc). 2012; 77: 339-341.
32. Rajaie S, Azadbakht L, Khazaei M, Esmaillzadeh A. Effect of moderately-restricted carbohydrate diet on cardiovascular risk factors among women with metabolic syndrome. J Isfahan Med School. 2012; 29: 1-17
33. McLaughlin T, Carter S, Lamendola C, et al. Effects of moderate variations in macronutrient composition on weight loss and reduction in cardiovascular disease risk in obese, insulinresistant adults. Am J Clin Nutr. 2006; 84: 813-821.
34. Seshadri P, Samaha FF, Stern L, Ahima RS, Daily D, Iqbal N. Adipocytokine changes caused by low-carbohydrate compared to conventional diets in obesity. Metab Syndr Relat Disord. 2005; 3: 66-74.
35. Tay J, Brinkworth GD, Noakes M, Keogh J, Clifton PM. Metabolic effects of weight loss on a very-low-carbohydrate diet compared with an isocaloric high-carbohydrate diet in abdominally obese subjects. J Am Coll Cardiol. 2008; 51: 59-67.
36. Al-Sarraj T, Saadi H, Calle MC, Volek JS, Fernandez ML. Carbohydrate restriction, as a first-line dietary intervention, effectively reduces biomarkers of metabolic syndrome in Emirati adults. J Nutr. 2009; 139: 1667-1676.
37. Peairs AT, Rankin JW. Inflammatory response to a high-fat, low-carbohydrate weight loss diet: effect of antioxidants. Obesity (Silver Spring). 2008; 16: 1573-1578.
38. Seshadri P, Iqbal N, Stern L, et al. A randomized study comparing the effects of a lowcarbohydrate diet and a conventional diet on lipoprotein subfractions and C-reactive protein levels in patients with severe obesity. Am J Med. 2004; 117: 398-405.
39. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Grag R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes and inflammation. Circulation. 2005; 111: 1448-1454.
40. Mohanty P, Hamouda W, Garg R, Aljada A, Ghanim H, Dandona P. Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endocrinol Metab. 2000; 85: 2970-2973.
41. Deopurkar R, Ghanim H, Friedman J, et al. Differential effects of cream, glucose, and orange juice on inflammation, endotoxin, and the expression of Toll-like receptor-4 and suppressorof cytokine signaling-3. Diabetes Care. 2010; 33: 991-997.
42. Aljada A, Ghanim H, Mohanty P, Syed T, Bandyopadhyay A, Dandona P. Glucose intake induces an increase in activator protein 1 and early growth response 1 binding activities, in the expression of tissue factor and matrix metalloproteinase in mononuclear cells, and in plasma tissue factor and matrix metalloproteinase concentrations. Am J Clin Nutr. 2004; 80: 51-57.
43. Klop B, Proctor SD, Mamo JC, Botham KM, Castro Cabezas M. Understanding postprandial inflammation and its relationship to lifestyle behaviour and metabolic diseases. Int J Vasc Med. 2012; 2012: 947417.
44. Stern SE, Williams K, Ferrannini E, DeFronzo RA, Bogardus C, Stern MP. Identification of individuals with insulin resistance using routine clinical measurements. Diabetes. 2005; 54: 333-339.
45. McLaughlin T, Abbasi F, Lamendola C, et al. Differentiation between obesity and insulin resistance in the association with C-reactive protein. Circulation. 2002; 106: 2908-2912.